Free tool
Oncology stocks
We cover 94 companies grouped under the Oncology theme. The median market value in the group is $794.35M. Across the group, the median move over the past trading day is +2.09%. 70% of the 91 with a 200-day average trade above it. Price change over the past year runs from −21.8% to +314.7% across the middle 80 percent of the group, with a median of +55.9%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
94 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $380.73B | Mega cap | +83.96% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $371.70B | Mega cap | +88.17% | Oct 29, 2026 |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +1.98% | Oct 30, 2026 |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +7.60% | Oct 30, 2026 |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +62.22% | Oct 29, 2026 |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +79.61% | Nov 5, 2026 |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +212.13% | Nov 3, 2026 |
| ERAS | Erasca, Inc. | $6.16B | Mid cap | +1016.98% | Nov 11, 2026 |
| RLAY | Relay Therapeutics, Inc. | $4.51B | Mid cap | +486.04% | Nov 5, 2026 |
| CELC | Celcuity Inc. | $4.44B | Mid cap | +87.35% | Nov 11, 2026 |
| TNGX | Tango Therapeutics, Inc. | $4.13B | Mid cap | +264.73% | Nov 4, 2026 |
| RCUS | Arcus Biosciences, Inc. | $4.02B | Mid cap | +211.03% | Oct 27, 2026 |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +196.22% | Nov 5, 2026 |
| ZLAB | Zai Lab Limited | $2.94B | Mid cap | −23.10% | Nov 5, 2026 |
| SLS | SELLAS Life Sciences Group, Inc. | $2.89B | Mid cap | +637.70% | Nov 11, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% | Oct 8, 2026 |
| NUVB | Nuvation Bio Inc. | $2.49B | Mid cap | +146.53% | Nov 2, 2026 |
| URGN | UroGen Pharma Ltd. | $2.27B | Mid cap | +150.59% | Nov 5, 2026 |
| XNCR | Xencor, Inc. Common Stock | $2.18B | Mid cap | +265.79% | Nov 4, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.12B | Mid cap | +341.09% | Sep 29, 2026 |
| NBTX | Nanobiotix S.A. | $2.11B | Mid cap | +321.42% | Sep 29, 2026 |
| NVCR | NovoCure Limited | $2.05B | Mid cap | +50.60% | Oct 29, 2026 |
| ZYME | Zymeworks Inc. | $1.96B | Small cap | +88.54% | Nov 5, 2026 |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +14.76% | Nov 5, 2026 |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +800.59% | Nov 5, 2026 |
| GXE.DE | Lakefront Biotherapeutics NV | $1.89B | Small cap | −44.50% | Nov 12, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.81B | Small cap | +144.52% | Nov 4, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +390.10% | Nov 13, 2026 |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +27.20% | Nov 2, 2026 |
| BCAX | Bicara Therapeutics Inc. | $1.63B | Small cap | +117.14% | Nov 10, 2026 |
| AVBP | ArriVent BioPharma, Inc. | $1.55B | Small cap | +62.02% | Nov 16, 2026 |
| REPL | Replimune Group, Inc. | $1.49B | Small cap | +187.80% | Nov 5, 2026 |
| AKTS | Aktis Oncology, Inc. | $1.48B | Small cap | +19.15% | Nov 12, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +200.39% | Nov 5, 2026 |
| IMTX | Immatics N.V. | $1.26B | Small cap | +76.67% | Nov 17, 2026 |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.24B | Small cap | +217.21% | Nov 5, 2026 |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.16% | Nov 3, 2026 |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +4.54% | Nov 13, 2026 |
| JANX | Janux Therapeutics, Inc. | $1.14B | Small cap | −18.82% | Nov 5, 2026 |
| KURA | Kura Oncology, Inc. | $1.10B | Small cap | +77.65% | Nov 3, 2026 |
| CADL | Candel Therapeutics, Inc. | $1.04B | Small cap | +138.18% | Nov 12, 2026 |
| GERN | Geron Corporation | $995.83M | Small cap | +9.15% | Nov 4, 2026 |
| EUZ.DE | Eckert & Ziegler SE | $963.05M | Small cap | −23.06% | Nov 12, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | $954.60M | Small cap | +95.17% | Nov 9, 2026 |
| 4587.T | PeptiDream Inc. | $902.75M | Small cap | −28.26% | Nov 11, 2026 |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +14.75% | Nov 3, 2026 |
| AURA | Aura Biosciences, Inc. | $810.97M | Small cap | +19.94% | Nov 12, 2026 |
| NVCT | Nuvectis Pharma, Inc. | $777.72M | Small cap | +298.92% | Nov 3, 2026 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −3.50% | Nov 11, 2026 |
| MNPR | Monopar Therapeutics Inc. | $747.47M | Small cap | +264.30% | Nov 12, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $734.32M | Small cap | +68.50% | Nov 5, 2026 |
| GUD.TO | Knight Therapeutics Inc. | $692.32M | Small cap | +49.08% | Nov 5, 2026 |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −16.33% | Nov 12, 2026 |
| 0QAV.L | Nanobiotix S.A. | $671.98M | Small cap | +346.30% | Sep 29, 2026 |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −21.16% | Nov 3, 2026 |
| SGMT | Sagimet Biosciences Inc. | $639.61M | Small cap | +45.34% | Nov 12, 2026 |
| ARVN | Arvinas, Inc. | $610.71M | Small cap | +28.34% | Nov 4, 2026 |
| DCTH | Delcath Systems, Inc. | $587.10M | Small cap | +55.37% | Nov 3, 2026 |
| 0KCS.L | OPKO Health, Inc. | $578.38M | Small cap | +5.63% | Oct 28, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $524.86M | Small cap | +418.90% | Nov 11, 2026 |
| CCCC | C4 Therapeutics, Inc. | $516.71M | Small cap | +66.01% | Nov 5, 2026 |
| 0IL8.L | Kyntra Bio, Inc. | $512.46M | Small cap | −24.41% | Nov 9, 2026 |
| PBYI | Puma Biotechnology, Inc. | $470.77M | Small cap | +86.77% | Nov 5, 2026 |
| 0LOV.L | Verastem, Inc. | $470.33M | Small cap | −21.47% | Nov 3, 2026 |
| CMPX | Compass Therapeutics, Inc. | $455.62M | Small cap | −16.23% | Nov 5, 2026 |
| FENC | Fennec Pharmaceuticals Inc. | $410.64M | Small cap | +35.38% | Nov 12, 2026 |
| FHTX | Foghorn Therapeutics Inc. | $406.79M | Small cap | +30.48% | Nov 5, 2026 |
| PRTC.L | PureTech Health plc | $402.61M | Small cap | −11.34% | Aug 27, 2026 |
| FRX.TO | Fennec Pharmaceuticals Inc. | $392.65M | Small cap | +27.38% | Nov 12, 2026 |
| AGEN | Agenus Inc. | $376.28M | Small cap | +90.43% | Nov 5, 2026 |
| CATX | Perspective Therapeutics, Inc. | $375.56M | Small cap | −4.91% | Nov 9, 2026 |
| 0XOD.L | UroGen Pharma Ltd. | $347.24M | Small cap | +136.32% | Nov 5, 2026 |
| BCYC | Bicycle Therapeutics plc | $306.47M | Small cap | −38.34% | Oct 29, 2026 |
| WHWK | Whitehawk Therapeutics, Inc. | $278.20M | Small cap | +198.82% | Nov 5, 2026 |
| ALXO | ALX Oncology Holdings Inc. | $276.55M | Small cap | +81.82% | Nov 6, 2026 |
| MGNX | MacroGenics, Inc. Common Stock | $265.63M | Small cap | +154.27% | Nov 12, 2026 |
| GLSI | Greenwich LifeSciences, Inc. | $258.04M | Small cap | +56.35% | Nov 12, 2026 |
| 0IV3.L | Geron Corporation | $255.34M | Small cap | +8.41% | Nov 4, 2026 |
| PYXS | Pyxis Oncology, Inc. | $255.23M | Small cap | +120.14% | Nov 2, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +1.34% | Sep 17, 2026 |
| IDD.DE | Innate Pharma S.A. | $247.30M | Small cap | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $244.95M | Small cap | +1.84% | Sep 17, 2026 |
| TARA | Protara Therapeutics, Inc. | $234.61M | Small cap | +30.16% | Nov 10, 2026 |
| CHRS | Coherus Oncology, Inc. | $211.67M | Small cap | +17.09% | Nov 5, 2026 |
| BINV.ST | BioInvent International AB (publ) | $169.15M | Small cap | −24.30% | Aug 27, 2026 |
| 0IMT.L | Photocure ASA | $144.18M | Small cap | −12.59% | Oct 28, 2026 |
| ADCT | ADC Therapeutics SA | $132.77M | Small cap | −66.34% | Nov 10, 2026 |
| HURA | TuHURA Biosciences, Inc. | $130.00M | Small cap | −30.85% | Nov 13, 2026 |
| 0RU5.L | Oncoinvent ASA | $128.23M | Small cap | +5951.72% | Aug 27, 2026 |
| BDTX | Black Diamond Therapeutics, Inc. | $123.81M | Small cap | −21.95% | Nov 5, 2026 |
| ANIX | Anixa Biosciences, Inc. | $123.16M | Small cap | +22.00% | Sep 9, 2026 |
| NTHI | NeOnc Technologies Holdings, Inc. | $122.16M | Small cap | −18.72% | Nov 12, 2026 |
| HBP.TO | Helix BioPharma Corp. | $109.87M | Small cap | +35.37% | Oct 29, 2026 |
| ONCY | Oncolytics Biotech Inc. | $109.84M | Small cap | −12.99% | Nov 16, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.